PROFUSA, INC. Ttl Fee Amt
PROFUSA, INC. (PFSA) had Ttl Fee Amt of $14.57 thousand as of 2026-04-22, per its S-1 filed 2026-04-28.
Financial Statements › Notes
ffd:TtlFeeAmt · last filed 2026-04-28
- 2026-04-22: Ttl Fee Amt $14.57K.
| Period end | Ttl Fee Amt |
|---|---|
| 2026-04-22 | $14.57K S-1 · filed 2026-04-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |